RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN

被引：0
|
作者：
Gomez-Codina, J. [1 ]
Giraldo, P. [2 ]
机构：
[1] Univ Hosp La Fe, Valencia, Spain
[2] Hosp U Miguel Servet, Dept Haematol, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [31] Radioimmunotherapy for NHL:: Experience of 90Y-ibritumomab tiuxetan in clinical practice
    Hagenbeek, A
    LEUKEMIA & LYMPHOMA, 2003, 44 : S37 - S47
  • [32] Comparison between 2D and 3D dosimetry protocols in 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma
    Assie, Karine
    Dieudonne, Arnaud
    Gardin, Isabelle
    Buvat, Irene
    Tilly, Herve
    Vera, Pierre
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (01) : 53 - 64
  • [33] Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma:: Combined data from 4 clinical trials
    Wiseman, GA
    Kornmehl, E
    Leigh, B
    Erwin, WD
    Podoloff, DA
    Spies, S
    Sparks, RB
    Stabin, MG
    Witzig, T
    White, CA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (03) : 465 - 474
  • [34] 90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging
    Iagaru, Andrei
    Gambhir, Sanjiv Sam
    Goris, Michael L.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) : 1809 - 1812
  • [35] 90Y-IBRITUMOMAB TIUXETAN TREATMENT FOR RELAPSED AND/OR REFRACTORY B CELL NON-HODGKIN'S LYMPHOMA. MULTI-INSTITUTIONAL ARGENTINIAN STUDY
    Cacchione, R.
    Milone, J.
    Nucifora, E.
    Bordone, J.
    Dupont, J.
    Rudoy, S.
    Brown, M.
    Lafalce, D.
    Palmer, L.
    Argentieri, D.
    Negri, P.
    Bartomioli, M.
    Milone, G.
    Trouboul, A.
    Ardaiz, M.
    Iabstrebner, M.
    Pombo, G.
    Basso, A.
    Diaz, A.
    Tur, R.
    Saidon, G.
    Krupitzki, H.
    Garay, G.
    Riveros, D.
    Carrasco, A.
    Chiattone, C.
    Bezares, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 109 - 109
  • [36] Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma
    Witzig, TE
    Flinn, IW
    Gordon, LI
    Emmanouilides, C
    Czuczman, MS
    Saleh, MN
    Cripe, L
    Wiseman, G
    Olejnik, T
    Multani, PS
    White, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3262 - 3269
  • [37] Radioimmunotherapy in non-Hodgkin's lymphoma: Trials of yttrium 90-labeled ibritumomab tiuxetan and beyond
    Evens, AM
    Gordon, LI
    CLINICAL LYMPHOMA, 2004, 5 : S11 - S15
  • [38] Imaging with 111In-Ibritumomab and 18F-FDG PET/CT in 90Y-Ibritumomab radioimmunotherapy of non-Hodgkin's lymphoma
    Banzo, I.
    Martinez-Rodriguez, I.
    Quirce, R.
    Jimenez-Bonilla, J.
    Sainz-Esteban, A.
    Barragan, J.
    Portilla-Quattrociocchi, H.
    Medina-Quiroz, P.
    Carril, J.
    Marques Valdecilla, H. U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S419 - S419
  • [39] Efficacy of 90 Y - Ibritumomab Tiuxetan in Relapsed or Refractory Primary Gastric Non Hodgkin Lymphoma
    Vanazzi, Anna
    Ferrucci, Pier Francesco
    Grana, Chiara Maria
    Pruneri, Giancarlo
    Crosta, Cristiano
    Pinto, Antonello
    Chinol, Marco
    Calabrese, Liliana
    Paganelli, Giovanni
    Martinelli, Giovanni
    BLOOD, 2008, 112 (11) : 1052 - 1053
  • [40] Impact of Rituximab Treatment on 90Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma
    Shen, Sui
    Forero, Andres
    Meredith, Ruby F.
    Shah, Jatin J.
    Knox, Susan J.
    Wiseman, Gregory A.
    Usrey, Marc E.
    LoBuglio, Albert F.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (01) : 150 - 157
12345